[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:pancreatic-ductal-adenocarcinoma:ras-family-oncogene":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Pancreatic Ductal Adenocarcinoma","RAS Family Oncogene",3,[8,16,23],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06983743","A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors",[12],"Phase 1","RECRUITING","2026-08-26T02:18:21.216897Z","2026-07-05T03:45:20.456891Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05379985","Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS",[20],"Phase 1\u002FPhase 2","2026-08-26T02:17:49.709549Z","2026-05-05T02:43:29.015195Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT06804824","A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors",[12],"2026-08-26T02:17:13.277148Z","2026-05-05T02:43:28.192980Z"]